BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SA1211 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SA1211\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07275918-10067@assetmemo.bio
DTSTAMP:20261121T004553Z
DTSTART;VALUE=DATE:20270330
DTEND;VALUE=DATE:20270331
SUMMARY:SA1211: Phase 1 readout est. (NCT07275918)
DESCRIPTION:SA1211\, phase 1\, Chronic Hepatitis B.\nStudy: SA1211 Injectio
 n Phase 1 Study\nEstimated primary completion: 30 March 2027. This is a Cl
 inicalTrials.gov estimate\, not a confirmed readout date\, and it can move
 .\nDrug page: https://assetmemo.bio/drug/sa1211#upcoming-events\nRegistry 
 record: https://clinicaltrials.gov/study/NCT07275918
URL:https://assetmemo.bio/drug/sa1211#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
